Navigation Links
Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
Date:5/6/2008

$- $-

Operating expenses:

Research and development 6,336 5,500

General and administrative 4,183 2,400

Total operating expenses 10,519 7,900

Loss from operations (10,519) (7,900)

Other income (expense), net 664 171

Net loss (9,855) (7,729)

Preferred stock dividends (125) (125)

Loss applicable to common shares $(9,980) $(7,854)

Loss per share:

Basic and diluted $(0.29) $(0.34)

Shares used in calculation of loss per share:

Basic and diluted 34,681 22,808

Condensed Consolidated Balance Sheets

(In thousands)

(Unaudited)

March 31, December 31,

2008 2007

ASSETS:

Cash and investment securities $84,694 $92,621

Cash - restricted 281 281

Facilities and equipment, net 1,085 1,121

Licensed products, net 9,717 10,021

Other assets 1,341 1,096

Total assets $97,118 $105,140

LIABILITIES AND SHAREHOLDERS' EQUITY:

Current liabilities $9,956 $9,474

Long term liabilities 5,606 6,561

Shareholders' equity 81,556
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
3. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
5. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
6. Onyx Pharmaceuticals Reports 2008 First Quarter Results
7. SGX Pharmaceuticals Schedules Teleconference and Webcast to Discuss First Quarter 2008 Results and Provide Pipeline Update
8. Israels Prestigious Presidents Conference to Feature Oramed Pharmaceuticals Revolutionary Oral Insulin Capsule
9. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
10. Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference
11. GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 Trigemina, Inc., a ... non-narcotic, nasally delivered, analgesic drug products, announced today that ... the position of chief medical officer. Dr. Kori brings ... much of which has been focused in the neuroscience ... add Dr. Kori to our clinical team given his ...
(Date:8/4/2015)... , ... August 04, 2015 , ... On August 4, ... a diverse selection of entrepreneurs from across the United States to talk about their ... is honored to be chosen to be among the attendees. , One of the ...
(Date:8/3/2015)... 2015 At the 11th hour, ... waved the shortfall of Jude Liversage,s campaign ... the first time.      (Photo: http://photos.prnewswire.com/prnh/20150803/254228 ... ) The Selective Dorsal Rhizotomy (SDR) procedure ... carry out his wish to kick a ball around ...
(Date:8/3/2015)... SAN DIEGO , Aug. 3, 2015  Aethlon Medical, ... affinity biofiltration devices to treat life-threatening diseases, today announced ... investor conference call and webcast on Thursday, August 13, ... call and webcast will follow the release of fiscal ... call will be available approximately two hours after the ...
Breaking Biology Technology:Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 2Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 3White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2
... Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: ... exhibit the CT Laser Mammography (CTLM(R)) system at the Arab ... Arab Emirates (UAE). The company will demonstrate the CTLM ... UAE and intends to secure prospective sales of the CTLM ...
... and consulting firm, Fadel Partners Inc., a certified partner ... year revenue growth of 13% for 2008, and expects ... company,s report stands in contrast to analyst estimates of ... U.S. IT services industry overall, as the economic downturn ...
... Development Program Has Been Approved For Second-Year Funding ... of the Chief Scientist-NES-ZIONA, Israel, Jan. 27 ... that its Israeli-based R&D subsidiary has received approval ... Office of the Chief Scientist ("OCS") in support ...
Cached Biology Technology:Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference 2Fadel Partners Announces 13% Growth Despite IT Services Industry Downtrend 2Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone 2Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone 3Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone 4
(Date:7/31/2015)... Den 10. internationale konference om Genomik (ICG-10, ... - 25. oktober i Shenzhen , ... i år. Siden starten i 2006 er ICB blevet ... og er en af de mest dynamiske, entusiastiske og ... nylige gennembrud og fremskridt inden for ,omik,-forskning, som yderligere ...
(Date:7/31/2015)... La 10 th International Conference on Genomics ... 22 al 25 de octubre de 2015 en ... conferencia celebra su décimo aniversario. Desde su inauguración en el ... reuniones anuales más influyentes del mundo en el campo ,ómico, ... y mejores a nivel científico. ICG-10 se ...
(Date:7/30/2015)... , July 30, 2015 Cellecta, ... for gene function analysis and biomarker discovery, announced ... (sgRNA) Knockout Library targeting all human protein coding ... permanently "knock out" a gene,s function. Cellecta,s new ... high throughput screening tool so that researchers can ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2
... to reduce sickness and death from infections that patients ... identifying ways to reduce the problem at its source. ... cubes or to rinse medical equipment is increasingly being ... contribute to many of these life-threatening infections. , Infection ...
... Commissioner Antonia C. Novello, M.D., M.P.H., Dr.P.H., today announced ... and Education campaign to help combat the potential spread ... virus that causes AIDS. , Dr. Novello said, "In ... strain of HIV in New York City, we must ...
... characteristic of diverse species of birds, but how this ... proves useful have remained uncertain. Researchers this week report ... bobbing is critical for the stabilization of their visual ... enables the accurate detection of objects such as food ...
Cached Biology News:Distributed Basic Local Alignment Search Toolkit (W.ND-BLAST) 2Distributed Basic Local Alignment Search Toolkit (W.ND-BLAST) 3AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV 2AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV 3Bobbing birds do it for a reason 2
Derlin-2 (C-18)...
CBF-B (G-2)...
Mouse monoclonal [164-12-2] to Ampicillin ( Abpromise for all tested applications)....
Flotillin-2 (ESA) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 29, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
Biology Products: